NeuVax

nelipepimut-S · Galena Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NeuVax, covering 2017-02-27 to 2023-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients [Phase 2]

See pricing